Development of measles virus-based shielded oncolytic vectors: suitability of other paramyxovirus glycoproteins

Targeted lentiviral vectors pseudotyped with the Tupaia paramyxovirus glycoproteins

(2012) T Enkirch et al.   GENE THERAPY

Feline morbillivirus, a previously undescribed paramyxovirus associated with tubulointerstitial nephritis in domestic cats

(2012) P. C. Y. Woo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Bats host major mammalian paramyxoviruses

(2012) Jan Felix Drexler et al.   Nature Communications

The Paramyxovirus Fusion Protein C-Terminal Region: Mutagenesis Indicates an Indivisible Protein Unit

(2011) A. Zokarkar et al.   JOURNAL OF VIROLOGY

Envelope-chimeric Entry-targeted Measles Virus Escapes Neutralization and Achieves Oncolysis

(2011) Tanner S Miest et al.   MOLECULAR THERAPY

Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

(2010) E. Galanis et al.   CANCER RESEARCH

Multiple Interactions between the ESCRT Machinery and Arrestin-Related Proteins: Implications for PPXY-Dependent Budding

(2010) S. Rauch et al.   JOURNAL OF VIROLOGY

A strategy for genetic modification of the spike-encoding segment of human reovirus T3D for reovirus targeting

(2008) D J M van den Wollenberg et al.   GENE THERAPY

Dynamic Interaction of the Measles Virus Hemagglutinin with Its Receptor Signaling Lymphocytic Activation Molecule (SLAM, CD150)

(2008) Chanakha K. Navaratnarajah et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Targeted Cell Entry of Lentiviral Vectors

(2008) Sabrina Funke et al.   MOLECULAR THERAPY

Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded

(2008) Roberto Cattaneo et al.   NATURE REVIEWS MICROBIOLOGY

Mechanisms for enveloped virus budding: Can some viruses do without an ESCRT?

(2007) Benjamin J. Chen et al.   VIROLOGY